Beijing Cancer hospital-intrathoratic deparmtment II ( Site 4510)

Beijing, Beijing Municipality 100142

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Non-small Cell Lung Cancer

Studies at this site

• A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77) — Running, not enrolling